News

Nexus Pharmaceuticals chose southeastern Wisconsin as the home for its first injectable drug manufacturing facility.

M7 Success Story: Nexus Pharmaceuticals

Published Thursday, July 1, 2021
by M7 News

 

Project Metrics

INDUSTRY
Pharmaceutical Manufacturing

DIRECT JOBS
200

CAPITAL EXPENDITURE
$250 million

REAL ESTATE
15 acres, 200,000 square feet

LOCATION
Pleasant Prairie, Wisconsin


“M7 did an excellent job communicating the Wisconsin value proposition, which factored importantly into our decision to site our new production operation in Pleasant Prairie.”

MARIAM DARSOT
CEO of Nexus Pharmaceuticals


Nexus is a woman-owned, privately held pharmaceutical company headquartered in Lincolnshire, IL, and produces specialty and generic injectable drugs relied upon by hospitals across the U.S. Milwaukee 7 (M7) assisted the company in its site search and led conversations with state and local partners to enable the project. The new Pleasant Prairie facility will support the production and supply of drugs in an array of therapeutic areas, including anesthesia, oncology, cardiovascular and neurology.

M7 continues to support Nexus Pharmaceuticals with workforce development through connections to local colleges, universities, and other regional partners.

 

Top reasons Nexus chose the MKE Region

  1. Trusted and reliable partnerships with state, regional and local organizations
  2. Access to highway and high-quality infrastructure
  3. Favorable tax climate